FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036743448> ?p ?o ?g. }

• W3036743448 endingPage "199" @default.
• W3036743448 startingPage "199" @default.
• W3036743448 abstract "Cardiovascular disease (CAD) associated with death and disability remains a serious medical problem. In some patients the initial clinical coronary artery disease presentation is stable angina pectoris.The aim of the study was to evaluate the effect of EECP therapy with or without trimetazidine (TMZ) in patients with refractory angina via modulating peripheral monocyte expression of Toll like receptor2 (TLR2) and its downstream signaling.This is a double-blind randomized prospective study in which 88 stable refractory angina patients allocated into two groups, Enhanced External Counter Pulsation (EECP) group: included 44 patients with stable refractory angina, and were treated with EECP-Therapy. TMZ-EECP group: included 44 patients with stable refractory angina, we gave TMZ 35 mg twice daily in addition to EECP-Therapy.TLR2 expression in peripheral monocyte investigated by flow cytometry and 8-iso-prostaglandin F2β (8-iso-PGF2 β), interleukin1β (IL-1β), heat shock protein 60 (HSP60) and monocytes chemoattractant protein-1(MCP-1) were also measured before the EECP-therapy and before giving TMZ to patients, and after 35 hours of EECP treatment (7 consecutive weeks). Inhibition in TLR2 expression in peripheral monocyte was observed among the EECP group (P<0.05). Inflammatory cytokine MCP-1 was remarkably decreased in both study groups but (heat shock protein 60 (HSP60), MCP-1 and interleukin-1β (IL-1β)) significantly decreased levels were observed among the TMZ-EECP group (P<0.05). Also, the oxidative stress biomarker 8-iso-prostaglandin F2β (8-iso-PGF2β) was decreased in both study groups but significantly decreased levels were observed among the TMZ-EECP group (P<0.05). TMZ and EECP therapy in patients with stable refractory angina remarkably decreased the inflammatory markers HSP60, MCP-1 and IL-1β in serum levels also the decreased levels were found in serum levels of oxidative stress marker 8-iso-PGF2β serum level.EECP-therapy decreased the expression of TLR2 on peripheral monocytes in patients with chronic stable refractory angina which yield improvement in the quality of patients' life by decreasing the frequency of angina episodes, decreasing the Short-acting nitrate use and change the exercise tolerance and distance." @default.
• W3036743448 created "2020-06-25" @default.
• W3036743448 creator A5028194199 @default.
• W3036743448 creator A5051094635 @default.
• W3036743448 creator A5060055342 @default.
• W3036743448 creator A5073823011 @default.
• W3036743448 creator A5087609544 @default.
• W3036743448 date "2020-01-01" @default.
• W3036743448 modified "2023-10-07" @default.
• W3036743448 title "Trimetazidine Improves the Outcome of EECP Therapy in Patients with Refractory Angina Pectoris" @default.
• W3036743448 cites W1516434930 @default.
• W3036743448 cites W1985065707 @default.
• W3036743448 cites W1987645607 @default.
• W3036743448 cites W1988150687 @default.
• W3036743448 cites W1988847492 @default.
• W3036743448 cites W1990022877 @default.
• W3036743448 cites W1992935548 @default.
• W3036743448 cites W1993793871 @default.
• W3036743448 cites W1997261949 @default.
• W3036743448 cites W2004689814 @default.
• W3036743448 cites W2007618030 @default.
• W3036743448 cites W2016514524 @default.
• W3036743448 cites W2025449580 @default.
• W3036743448 cites W2026734260 @default.
• W3036743448 cites W2032839313 @default.
• W3036743448 cites W2033924867 @default.
• W3036743448 cites W2036145275 @default.
• W3036743448 cites W2042815338 @default.
• W3036743448 cites W2051093466 @default.
• W3036743448 cites W2059778162 @default.
• W3036743448 cites W2074700312 @default.
• W3036743448 cites W2076078952 @default.
• W3036743448 cites W2076327713 @default.
• W3036743448 cites W2082066647 @default.
• W3036743448 cites W2103348550 @default.
• W3036743448 cites W2113684546 @default.
• W3036743448 cites W2116465329 @default.
• W3036743448 cites W2125345256 @default.
• W3036743448 cites W2130483595 @default.
• W3036743448 cites W2130668675 @default.
• W3036743448 cites W2140735579 @default.
• W3036743448 cites W2147284855 @default.
• W3036743448 cites W2147367812 @default.
• W3036743448 cites W2154115881 @default.
• W3036743448 cites W2161137175 @default.
• W3036743448 cites W2410325389 @default.
• W3036743448 cites W2414963831 @default.
• W3036743448 cites W2531272839 @default.
• W3036743448 cites W2614781785 @default.
• W3036743448 cites W2753838799 @default.
• W3036743448 cites W2919756826 @default.
• W3036743448 cites W2946860912 @default.
• W3036743448 cites W3013994575 @default.
• W3036743448 doi "https://doi.org/10.5455/medarh.2020.74.199-204" @default.
• W3036743448 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7406001" @default.
• W3036743448 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32801436" @default.
• W3036743448 hasPublicationYear "2020" @default.
• W3036743448 type Work @default.
• W3036743448 sameAs 3036743448 @default.
• W3036743448 citedByCount "4" @default.
• W3036743448 countsByYear W30367434482022 @default.
• W3036743448 countsByYear W30367434482023 @default.
• W3036743448 crossrefType "journal-article" @default.
• W3036743448 hasAuthorship W3036743448A5028194199 @default.
• W3036743448 hasAuthorship W3036743448A5051094635 @default.
• W3036743448 hasAuthorship W3036743448A5060055342 @default.
• W3036743448 hasAuthorship W3036743448A5073823011 @default.
• W3036743448 hasAuthorship W3036743448A5087609544 @default.
• W3036743448 hasBestOaLocation W30367434482 @default.
• W3036743448 hasConcept C121332964 @default.
• W3036743448 hasConcept C126322002 @default.
• W3036743448 hasConcept C142424586 @default.
• W3036743448 hasConcept C164705383 @default.
• W3036743448 hasConcept C2777927741 @default.
• W3036743448 hasConcept C2778213512 @default.
• W3036743448 hasConcept C2778425758 @default.
• W3036743448 hasConcept C500558357 @default.
• W3036743448 hasConcept C71924100 @default.
• W3036743448 hasConcept C87355193 @default.
• W3036743448 hasConcept C90924648 @default.
• W3036743448 hasConceptScore W3036743448C121332964 @default.
• W3036743448 hasConceptScore W3036743448C126322002 @default.
• W3036743448 hasConceptScore W3036743448C142424586 @default.
• W3036743448 hasConceptScore W3036743448C164705383 @default.
• W3036743448 hasConceptScore W3036743448C2777927741 @default.
• W3036743448 hasConceptScore W3036743448C2778213512 @default.
• W3036743448 hasConceptScore W3036743448C2778425758 @default.
• W3036743448 hasConceptScore W3036743448C500558357 @default.
• W3036743448 hasConceptScore W3036743448C71924100 @default.
• W3036743448 hasConceptScore W3036743448C87355193 @default.
• W3036743448 hasConceptScore W3036743448C90924648 @default.
• W3036743448 hasIssue "3" @default.
• W3036743448 hasLocation W30367434481 @default.
• W3036743448 hasLocation W30367434482 @default.
• W3036743448 hasLocation W30367434483 @default.
• W3036743448 hasLocation W30367434484 @default.
• W3036743448 hasOpenAccess W3036743448 @default.
• W3036743448 hasPrimaryLocation W30367434481 @default.

• next